HeyJaredRebooting Cancer Care by Doug Flora, MD
A practicing oncologist explores what it means to fight cancer in the age of AI—and why the most important technology we have is still human connection. Author of Rebooting Cancer Care, Editor-in-Chief of AI in Precision Oncology.
- Indexed issues, last 90 days
- 8
- Latest publication
- Sep 28, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 5, 2026
Latest issues
The Arrival of the Cancer Pre-patient (opens the original)
Read excerpt
Rather than practicing a philosophy of “watch and wait”until structural disease manifests, modern oncology is learning to use advanced biomarkers and targeted interventions to halt biological progression before invasive malignancy ever develops. <sour
Doctor-to-Doctor (opens the original)
Read excerpt
I turned the tables this month and interviewed an oncologist I deeply respect, Dr. Eleonora Teplinsky, MD, about the upcoming release of her new book, Beyond the Pink: Navigating Life, Health, and Breast Cancer. Dr. Flora: Bridging the Clinical Gap: You note that this book picks up where clinical visits leave off. What is the single biggest gap in traditional oncologic care that you hope Beyond the Pink fills for patients?Dr. Teplinsky: One of the bigg
Holding Both: On fear, wonder, and the quiet miracles of artificial intelligence (opens the original)
Read excerpt
“Responsible Execution is a choice.” -Ruth Porat, President, CIO, Alphabet<img alt="" class="sizing-normal" height="1148" src="https://substackcdn.com/image/fetch/$s_!aoXA!,w_1456,c_limit,f_auto,q_a
Why ‘Incurable’ Cancer Won’t Stay That Way (opens the original)
Read excerpt
<img alt="" class="sizing-normal" height="941" src="https://substackcdn.com/image/fetch/$s_!_Wqq!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F2fa9303b-a9d0-4ecf-8dda-7a08b91ea147_1672x9
What If Everything We Know About Cancer Screening Is Wrong? (opens the original)
Read excerpt
"Our legacy screening rules were built to find an established, billion-cell mass. But when detection enters the molecular realm, we are no longer just sharpening our tools. We are confronting a biologically different problem."<img alt="" cl
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.